Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

被引:61
|
作者
Radfar, Seyed Ramin [1 ,2 ]
De Jong, Cornelis A. J. [3 ]
Farhoudian, Ali [4 ]
Ebrahimi, Mohsen [5 ,6 ]
Rafei, Parnian [7 ]
Vahidi, Mehrnoosh [4 ]
Yunesian, Masud [8 ]
Kouimtsidis, Christos [9 ]
Arunogiri, Shalini [10 ]
Massah, Omid [11 ]
Deylamizadeh, Abbas [12 ]
Brady, Kathleen T. [13 ]
Busse, Anja [14 ]
Potenza, Marc N. [15 ]
Ekhtiari, Hamed [16 ,17 ]
Baldacchino, Alexander Mario [18 ]
机构
[1] Univ Tehran Med Sci, Sch Adv Technol Med SATiM, Dept Neurosci & Addict, Tehran, Iran
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs Dept, Los Angeles, CA USA
[3] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands
[4] Univ Tehran Med Sci, Dept Psychiat, Tehran, Iran
[5] Mat & Energy Res Ctr, Tehran, Iran
[6] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Tehran, Iran
[7] Univ Tehran, Fac Psychol & Educ, Dept Psychol, Tehran, Iran
[8] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran
[9] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England
[10] Eastern Hlth, Turning Point, Box Hill, Vic, Australia
[11] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Tehran, Iran
[12] Rebirth Char Soc NGO, Tehran, Iran
[13] Med Univ South Carolina, Charleston, SC 29425 USA
[14] United Nations Off Drugs & Crime, Drug Prevent & Hlth Branch, Div Operat, Prevent Treatment & Rehabil Sect, Vienna, Austria
[15] Yale Sch Med, Connecticut Council Problem Gambling, New Haven, CT USA
[16] Yale Sch Med, Connecticut Mental Hlth Ctr, New Haven, CT USA
[17] Laureate Inst Brain Res, Tulsa, OK USA
[18] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 12卷
关键词
COVID-19; pandemic; substance use disorder; public health; drug policy; opioid agonist treatment; addiction services; harm reduction; CLIMATE-CHANGE; USE DISORDER; PEOPLE; VULNERABILITY; IMMUNITY; STRESS; IMPACT;
D O I
10.3389/fpsyt.2021.639393
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
引用
收藏
页数:16
相关论文
共 50 条
  • [11] Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic
    Sugarman, Dawn E.
    Busch, Alisa B.
    McHugh, R. Kathryn
    Bogunovic, Olivera J.
    Trinh, Catherine D.
    Weiss, Roger D.
    Greenfield, Shelly F.
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (05): : 445 - 452
  • [12] The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals
    Bosch-Aris, Mar
    Gasulla, Laia
    de Gispert, Teresa
    Segura, Lidia
    Colom, Joan
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [13] The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals
    Mar Bosch-Arís
    Laia Gasulla
    Teresa de Gispert
    Lidia Segura
    Joan Colom
    Harm Reduction Journal, 19
  • [14] Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey
    Saloner, Brendan
    Krawczyk, Noa
    Solomon, Keisha
    Allen, Sean T.
    Morris, Miles
    Haney, Katherine
    Sherman, Susan G.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 101
  • [15] Reduction in IEP Services During the COVID-19 Pandemic
    Rasmussen, P.
    Chen, B.
    Legg, M.
    Alexander, N.
    Vedmurthy, P.
    Zabel, A.
    Comi, A.
    Leppert, M.
    ANNALS OF NEUROLOGY, 2021, 90 : S50 - S50
  • [16] Substance use during the COVID-19 pandemic in Greece
    Rantis, K.
    Panagiotidis, P.
    Parlapani, E.
    Holeva, V.
    Tsapakis, E. M.
    Diakogiannis, I.
    JOURNAL OF SUBSTANCE USE, 2022, 27 (03) : 231 - 238
  • [17] Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
    Noa Krawczyk
    Adetayo Fawole
    Jenny Yang
    Babak Tofighi
    Addiction Science & Clinical Practice, 16
  • [18] Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
    Krawczyk, Noa
    Fawole, Adetayo
    Yang, Jenny
    Tofighi, Babak
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [19] Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic
    Komaromy, Miriam
    Tomanovich, Mary
    Taylor, Jessica L.
    Ruiz-Mercado, Glorimar
    Kimmel, Simeon D.
    Bagley, Sarah M.
    Saia, Kelley M.
    Costello, Eileen
    Park, Tae Woo
    LaBelle, Colleen
    Weinstein, Zoe
    Walley, Alexander Y.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (06) : 448 - 451
  • [20] Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic
    Hsu, Michael
    Ahern, David K.
    Suzuki, Joji
    JMIR MENTAL HEALTH, 2020, 7 (10):